Related Experiment Video
Updated: Feb 14, 2026

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
Published on: June 30, 2019
A-Kinase Anchoring Protein-Lbc: A Molecular Scaffold Involved in Cardiac Protection
Dario Diviani1, Halima Osman2, Erica Reggi3
1Département de Pharmacologie et de Toxicologie, Faculté de Biologie et de Médecine, Lausanne 1005, Switzerland. Dario.diviani@unil.ch.
Insights
A-kinase anchoring proteins (AKAPs) are crucial for heart function after damage. AKAP-Lbc, a key AKAP, orchestrates protective signaling pathways in the stressed heart, offering therapeutic potential.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Cell Signaling
Background:
- Heart failure is a major cause of death, often resulting from cardiomyocyte death, cardiac remodeling, and fibrosis.
- A-kinase anchoring proteins (AKAPs) are scaffolding proteins that regulate cyclic adenosine monophosphate (AMP)-dependent protein kinase (PKA) and other signaling pathways.
- AKAP-Lbc is a cardiac-enriched AKAP involved in regulating cardiac remodeling and protection.
Purpose of the Study:
- To review and discuss recent advancements in understanding the role of the AKAP-Lbc signalosome.
- To highlight how AKAP-Lbc orchestrates adaptive responses in the stressed heart.
Main Methods:
- Literature review of recent studies on AKAP-Lbc and cardiac signaling.
- Analysis of molecular mechanisms underlying AKAP-Lbc function in cardiac remodeling.
- Discussion of the implications of AKAP-Lbc signaling in heart failure pathogenesis.
Main Results:
- AKAP-Lbc acts as a central coordinator of signaling pathways crucial for cardiac protection and remodeling.
- The AKAP-Lbc signalosome modulates cardiomyocyte survival and cardiac fibrosis.
- Dysregulation of AKAP-Lbc signaling contributes to the progression of heart failure.
Conclusions:
- AKAP-Lbc plays a pivotal role in the heart's adaptive response to stress.
- Targeting the AKAP-Lbc signalosome may offer novel therapeutic strategies for heart failure.
- Further research into AKAP-Lbc function is essential for developing effective treatments for cardiovascular diseases.
Abstract:
Heart failure is a lethal disease that can develop after myocardial infarction, hypertension, or anticancer therapy. In the damaged heart, loss of function is mainly due to cardiomyocyte death and associated cardiac remodeling and fibrosis. In this context, A-kinase anchoring proteins (AKAPs) constitute a family of scaffolding proteins that facilitate the spatiotemporal activation of the cyclic adenosine monophosphate (AMP)-dependent protein kinase (PKA) and other transduction enzymes involved in cardiac remodeling. AKAP-Lbc, a cardiac enriched anchoring protein, has been shown to act as a key coordinator of the activity of signaling pathways involved in cardiac protection and remodeling. This review will summarize and discuss recent advances highlighting the role of the AKAP-Lbc signalosome in orchestrating adaptive responses in the stressed heart.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
GPI Anchoring of Proteins in the ER Membrane
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
Tail-anchoring of Proteins in the ER Membrane
The Anchoring-and-Adjustment Heuristic
Molecular Chaperones and Protein Folding
The...

